» Authors » Graham R Williams

Graham R Williams

Explore the profile of Graham R Williams including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 4415
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Williams G
Thyroid . 2023 Oct; 34(1):10-13. PMID: 37885215
No abstract available.
2.
Loisay L, Komla-Ebri D, Morice A, Heuze Y, Viaut C, de La Seigliere A, et al.
JCI Insight . 2023 Jun; 8(12). PMID: 37345656
Hypochondroplasia (HCH) is a mild dwarfism caused by missense mutations in fibroblast growth factor receptor 3 (FGFR3), with the majority of cases resulting from a heterozygous p.Asn540Lys gain-of-function mutation. Here,...
3.
Kooblall K, Stevenson M, Stewart M, Harris L, Zalucki O, Dewhurst H, et al.
JBMR Plus . 2023 Jun; 7(6):e10739. PMID: 37283649
The nuclear factor I/X () gene encodes a ubiquitously expressed transcription factor whose mutations lead to two allelic disorders characterized by developmental, skeletal, and neural abnormalities, namely, Malan syndrome (MAL)...
4.
Perros P, Basu A, Boelaert K, Dayan C, Vaidya B, Williams G, et al.
Clin Endocrinol (Oxf) . 2022 Mar; 97(5):664-675. PMID: 35274331
Objective: Thyroid status in the months following radioiodine (RI) treatment for Graves' disease can be unstable. Our objective was to quantify frequency of abnormal thyroid function post-RI and compare effectiveness...
5.
Foessl I, Bassett J, Bjornerem A, Busse B, Calado A, Chavassieux P, et al.
Front Endocrinol (Lausanne) . 2021 Dec; 12:720728. PMID: 34925226
A synoptic overview of scientific methods applied in bone and associated research fields across species has yet to be published. Experts from the EU Cost Action GEMSTONE ("GEnomics of MusculoSkeletal...
6.
Lademann F, Mayerl S, Tsourdi E, Verrey F, Leitch V, Williams G, et al.
Endocrinology . 2021 Oct; 163(1). PMID: 34669927
Thyroid hormones (TH) are essential for skeletal development and adult bone homeostasis. Their bioavailability is determined by specific transporter proteins at the cell surface. The TH-specific transporter monocarboxylate transporter 8...
7.
Formosa M, Bergen D, Gregson C, Maurizi A, Kampe A, Garcia-Giralt N, et al.
Front Endocrinol (Lausanne) . 2021 Sep; 12:709711. PMID: 34539568
Genetic disorders of the skeleton encompass a diverse group of bone diseases differing in clinical characteristics, severity, incidence and molecular etiology. Of particular interest are the monogenic rare bone mass...
8.
Dekker B, Muller Kobold A, Brouwers A, Williams G, Nies M, Klein Hesselink M, et al.
Thyroid . 2021 Sep; 31(11):1707-1714. PMID: 34514857
Survivors of pediatric differentiated thyroid carcinoma (DTC) receive thyrotropin-suppressive therapy to minimize disease recurrence. However, knowledge about long-term effects of subclinical hyperthyroidism on bone mineral density (BMD) in pediatric DTC...
9.
Makitie R, Henning P, Jiu Y, Kampe A, Kogan K, Costantini A, et al.
JBMR Plus . 2021 Jul; 5(7):e10509. PMID: 34258505
Ras homologous guanosine triphosphatases (RhoGTPases) control several cellular functions, including cytoskeletal actin remodeling and cell migration. Their activities are downregulated by GTPase-activating proteins (GAPs). Although RhoGTPases are implicated in bone...
10.
Butterfield N, Curry K, Steinberg J, Dewhurst H, Komla-Ebri D, Mannan N, et al.
Nat Commun . 2021 May; 12(1):3302. PMID: 34050183
No abstract available.